Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
25795 | 272 | 38.8 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
747 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12474 |
25795 | 1 | MAJOR VAULT PROTEIN//VAULT//VPARP | 272 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MAJOR VAULT PROTEIN | authKW | 1846398 | 9% | 66% | 25 |
2 | VAULT | authKW | 1584354 | 14% | 38% | 37 |
3 | VPARP | authKW | 1234883 | 4% | 100% | 11 |
4 | LUNG RESISTANCE RELATED PROTEIN | authKW | 798290 | 6% | 44% | 16 |
5 | MVP | authKW | 715468 | 8% | 28% | 23 |
6 | VAULT COMPLEX | authKW | 673572 | 2% | 100% | 6 |
7 | MAJOR VAULT PROTEIN MVP | authKW | 449044 | 2% | 67% | 6 |
8 | VAULT PARTICLE | authKW | 336786 | 1% | 100% | 3 |
9 | LUNG RESISTANCE PROTEIN | authKW | 311825 | 4% | 28% | 10 |
10 | TEP1 | authKW | 261935 | 3% | 33% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 865 | 30% | 0% | 82 |
2 | Cell Biology | 222 | 16% | 0% | 44 |
3 | Biochemistry & Molecular Biology | 173 | 24% | 0% | 66 |
4 | Nanoscience & Nanotechnology | 67 | 6% | 0% | 17 |
5 | Biochemical Research Methods | 36 | 5% | 0% | 13 |
6 | Biophysics | 22 | 4% | 0% | 12 |
7 | Medicine, Research & Experimental | 16 | 4% | 0% | 11 |
8 | Pathology | 12 | 3% | 0% | 7 |
9 | Genetics & Heredity | 10 | 4% | 0% | 11 |
10 | Pharmacology & Pharmacy | 8 | 6% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MED BIOL CHEM 33257 CHS | 149681 | 1% | 67% | 2 |
2 | ADV MAT DISCOVERY | 112262 | 0% | 100% | 1 |
3 | BIO MULTISOME TEAM | 112262 | 0% | 100% | 1 |
4 | BIOL ANAT PATOL | 112262 | 0% | 100% | 1 |
5 | CHONGQING PEDIAT CHINA INT SCI TECHNOL | 112262 | 0% | 100% | 1 |
6 | CIENCIAS BIOLOGNUCLEO PESQUISA CIENCIAS BIO | 112262 | 0% | 100% | 1 |
7 | GYNAECOL GRAOSSHADERN | 112262 | 0% | 100% | 1 |
8 | MICROSCOPY ANAL IMAGING | 112262 | 0% | 100% | 1 |
9 | MINIST EDUC CHILD DEV DISORDERS PH | 112262 | 0% | 100% | 1 |
10 | MOL GR MODELING | 112262 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACS NANO | 1729 | 4% | 0% | 12 |
2 | ENERGY SOURCES PART B-ECONOMICS PLANNING AND POLICY | 795 | 1% | 0% | 2 |
3 | RADIATION ONCOLOGY | 564 | 1% | 0% | 3 |
4 | INTERNATIONAL JOURNAL OF CANCER | 438 | 3% | 0% | 9 |
5 | RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY | 430 | 0% | 0% | 1 |
6 | JOURNAL OF CELL BIOLOGY | 335 | 3% | 0% | 7 |
7 | GENOME BIOLOGY AND EVOLUTION | 329 | 1% | 0% | 2 |
8 | ANTICANCER RESEARCH | 277 | 3% | 0% | 7 |
9 | ONCOLOGY REPORTS | 275 | 2% | 0% | 5 |
10 | CELLULAR ONCOLOGY | 236 | 0% | 0% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MAJOR VAULT PROTEIN | 1846398 | 9% | 66% | 25 | Search MAJOR+VAULT+PROTEIN | Search MAJOR+VAULT+PROTEIN |
2 | VAULT | 1584354 | 14% | 38% | 37 | Search VAULT | Search VAULT |
3 | VPARP | 1234883 | 4% | 100% | 11 | Search VPARP | Search VPARP |
4 | LUNG RESISTANCE RELATED PROTEIN | 798290 | 6% | 44% | 16 | Search LUNG+RESISTANCE+RELATED+PROTEIN | Search LUNG+RESISTANCE+RELATED+PROTEIN |
5 | MVP | 715468 | 8% | 28% | 23 | Search MVP | Search MVP |
6 | VAULT COMPLEX | 673572 | 2% | 100% | 6 | Search VAULT+COMPLEX | Search VAULT+COMPLEX |
7 | MAJOR VAULT PROTEIN MVP | 449044 | 2% | 67% | 6 | Search MAJOR+VAULT+PROTEIN+MVP | Search MAJOR+VAULT+PROTEIN+MVP |
8 | VAULT PARTICLE | 336786 | 1% | 100% | 3 | Search VAULT+PARTICLE | Search VAULT+PARTICLE |
9 | LUNG RESISTANCE PROTEIN | 311825 | 4% | 28% | 10 | Search LUNG+RESISTANCE+PROTEIN | Search LUNG+RESISTANCE+PROTEIN |
10 | TEP1 | 261935 | 3% | 33% | 7 | Search TEP1 | Search TEP1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BERGER, W , STEINER, E , GRUSCH, M , ELBLING, L , MICKSCHE, M , (2009) VAULTS AND THE MAJOR VAULT PROTEIN: NOVEL ROLES IN SIGNAL PATHWAY REGULATION AND IMMUNITY.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 66. ISSUE 1. P. 43-61 | 92 | 61% | 81 |
2 | STEINER, E , HOLZMANN, K , ELBLING, L , MICKSCHE, M , BERGER, W , (2006) CELLULAR FUNCTIONS OF VAULTS AND THEIR INVOLVEMENT IN MULTIDRUG RESISTANCE.CURRENT DRUG TARGETS. VOL. 7. ISSUE 8. P. 923 -934 | 88 | 55% | 59 |
3 | LARA, PC , PRUSCHY, M , ZIMMERMANN, M , HENRIQUEZ-HERNANDEZ, LA , (2011) MVP AND VAULTS: A ROLE IN THE RADIATION RESPONSE.RADIATION ONCOLOGY. VOL. 6. ISSUE . P. - | 64 | 63% | 18 |
4 | YANG, J , NAGASAWA, DT , SPASIC, M , AMOLIS, M , CHOY, W , GARCIA, HM , PRINS, RM , LIAU, LM , YANG, I , (2012) ENDOGENOUS VAULTS AND BIOENGINEERED VAULT NANOPARTICLES FOR TREATMENT OF GLIOBLASTOMAS IMPLICATIONS FOR FUTURE TARGETED THERAPIES.NEUROSURGERY CLINICS OF NORTH AMERICA. VOL. 23. ISSUE 3. P. 451-+ | 58 | 67% | 1 |
5 | RYU, SJ , PARK, SC , (2009) TARGETING MAJOR VAULT PROTEIN IN SENESCENCE-ASSOCIATED APOPTOSIS RESISTANCE.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 13. ISSUE 4. P. 479-484 | 45 | 75% | 10 |
6 | CASANAS, A , GUERRA, P , FITA, I , VERDAGUER, N , (2012) VAULT PARTICLES: A NEW GENERATION OF DELIVERY NANODEVICES.CURRENT OPINION IN BIOTECHNOLOGY. VOL. 23. ISSUE 6. P. 972-977 | 30 | 91% | 4 |
7 | TANAKA, H , TSUKIHARA, T , (2012) STRUCTURAL STUDIES OF LARGE NUCLEOPROTEIN PARTICLES, VAULTS.PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES. VOL. 88. ISSUE 8. P. 416 -433 | 32 | 76% | 7 |
8 | MOSSINK, MH , VAN ZON, A , SCHEPER, RJ , SONNEVELD, P , WIEMER, EAC , (2003) VAULTS: A RIBONUCLEOPROTEIN PARTICLE INVOLVED IN DRUG RESISTANCE?.ONCOGENE. VOL. 22. ISSUE 47. P. 7458-7467 | 50 | 55% | 105 |
9 | VAN ZON, A , MOSSINK, MH , SCHEPER, RJ , SONNEVELD, P , WIEMER, EAC , (2003) THE VAULT COMPLEX.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 60. ISSUE 9. P. 1828-1837 | 43 | 64% | 55 |
10 | BENNER, NL , ZANG, XY , BUEHLER, DC , KICKHOEFER, VA , ROME, ME , ROME, LH , WENDER, PA , (2017) VAULT NANOPARTICLES: CHEMICAL MODIFICATIONS FOR IMAGING AND ENHANCED DELIVERY.ACS NANO. VOL. 11. ISSUE 1. P. 872 -881 | 29 | 71% | 0 |
Classes with closest relation at Level 1 |